tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Mok, 12 are a SELL (13.04%), 28 are a HOLD (30.43%), 52 are a BUY (56.52%).
Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 52.05% that have a potential upside of 14.61% achieved within 140 days. Previously, Andrew Mok worked at UBS.
Andrew Mok’s has documented 185 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCA, HCA Holdings at 08-Nov-2024.
Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for AMED (AMEDISYS) at 11/1/2022. The price target of $88 was fulfilled within 2 days with a profit of $7.12 (7.49%) receiving and performance score of 37.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$101
$10.96 (12.17%)
$101
3 months 21 days ago
(31-Jul-2024)
3/10 (30%)
$2.95 (3.01%)
70
Hold
$101
$10.96 (12.17%)
$101
3 months 27 days ago
(25-Jul-2024)
1/8 (12.5%)
$3.25 (3.32%)
45
Hold
7 months 26 days ago
(26-Mar-2024)
5/10 (50%)
$12.13 (9.49%)
99
Hold
$101
$10.96 (12.17%)
$84
1 years 3 months 21 days ago
(31-Jul-2023)
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
$101
$10.96 (12.17%)
$100
1 years 3 months 25 days ago
(27-Jul-2023)
0/5 (0%)
$10.5 (11.60%)
Which stock is Andrew Mok is most bullish on?
Which stock is Andrew Mok is most reserved on?
What Year was the first public recommendation made by Andrew Mok?
